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Abstract Binding affinity prediction is frequently
addressed using computational models constructed solely
with molecular structure and activity data. We present a
hybrid structure-guided strategy that combines molecular
similarity, docking, and multiple-instance learning such
that information from protein structures can be used to
inform models of structure–activity relationships. The
Surflex-QMOD approach has been shown to produce
accurate predictions of binding affinity by constructing an
interpretable physical model of a binding site with no
experimental binding site structural information. We
introduce a method to integrate protein structure informa-
tion into the model induction process in order to construct
more robust physical models. The structure-guided models
accurately predict binding affinities over a broad range of
compounds while producing more accurate representations
of the protein pockets and ligand binding modes. Structure-
guidance for the QMOD method yielded significant per-
formance improvements, both for affinity and pose pre-
diction, especially in cases where predictions were made on
ligands very different from those used for model induction.
Keywords QMOD  QSAR  Surflex  MM-PBSA 
Affinity prediction  Random forest
Introduction
The field of predictive modeling of chemical and biological
properties in medicinal chemistry has a long tradition of
pure ligand-focused model induction, starting with sub-
stituent-based QSAR approaches [1], continuing with the
elaboration of fragment- and descriptor-based methods [2,
3], and including physically oriented 3D QSAR approaches
[4–6]. Our introduction of the Surflex QMOD method [7]
continued in this vein, focusing on induction of binding site
models purely from ligand structures and associated
activity values. In the present study, we instead show that a
hybrid strategy that integrates information from experi-
mentally determined protein structures with structure–
activity data produces predictive models that are more
widely applicable and accurate for ligand affinity predic-
tion. Further, the strategy produces a binding pocket model
(a ‘‘pocketmol’’) directly related to the physical pocket.
The core, purely ligand-based, QMOD methodology
builds and tests a pocketmol in the following six steps:
1. Initial alignment hypothesis Two or three ligands are
chosen to serve as a seed alignment hypothesis, which
is derived by maximizing their mutual 3D molecular
similarity. The ligands are typically chosen to be
among the most active of available data and which
exhibit structural variation.
2. Training ligand alignment generation For each train-
ing molecule, the initial alignment hypothesis is used
to guide the generation of multiple poses (typically
100–200), again using 3D molecular similarity.
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3. Probe generation The collection of aligned active
training molecules (each in their multiplicity of poses)
are used to guide the placement of small molecular
probes that represent possible constituents of the
cognate binding pocket. Each individual training
ligand pose is tessellated by probes whose fine
positions are optimized for intermolecular interactions.
Those probes that are not redundant of previously
generated probes are retained, usually resulting in
several thousand such probes.
4. Probe subset selection A probe subset forming an
initial pocketmol is chosen to optimize multiple
constraints, the most important of which is that the
scores of training ligands against the pocketmol are
close to their experimental values. For each ligand, it is
the maximal scoring pose that defines its score.
5. Iterative model refinement The pocketmol is refined by
iteration of the following two steps. The process stops
when the final optimal ligand poses yield scores that
are close to the experimental values.
(a) Pocketmol refinement The fine positions of the
pocketmol probes are optimized such that the
deviation of computed training ligand scores to
experimental data is minimized.
(b) Ligand pose refinement The poses of each
training ligand are refined using the current
pocketmol in order to identify the optimal fit.
6. Prediction on new molecules The final pocketmol
serves as the target of a procedure very similar to
docking, in which new molecules are flexibly fit into
the pocketmol to seek the optimal score subject to
constraints on ligand energetics. The result produces a
prediction of affinity and pose along with a measure of
confidence.
The QMOD procedure is algorithmically complex,
combining aspects of molecular similarity [8–10], multi-
ple-instance machine-learning [11, 6], and docking [12–
14], but all steps are fully automated. We have shown that
the QMOD procedure is capable of making accurate pre-
dictions across varying chemical scaffolds [7], learning
non-additive structure–activity relationships [15, 16], and
guiding lead optimization toward potent and diverse
ligands [17].
However, there are two key areas, corresponding to
steps 1 and 3 above, which are particularly challenging
when making use of structure–activity data alone. The
initial alignment hypothesis is poorly constrained in the
case of data that are dominated by a single chemical series,
especially one with significant flexibility. In such a situa-
tion, many different initial alignment hypotheses can be
generated, all of which score equally well, but only one
solution will correspond well to the true binding pocket.
When this happens, it is possible to derive a pocketmol that
is highly predictive within the series but where predictions
are poor on molecules with divergent scaffolds [15]. In
practice, making use of multiple chemical series helps
ameliorate this problem, but better means to determine an
initial alignment hypothesis that represents the correct
absolute configuration would lead to more predictive
models. The probe generation process, step 3, is also poorly
constrained, proceeding blindly without knowledge of
where protein and solvent may be. Given limited structure–
activity data with which to select and refine probes for a
pocketmol, models can arise where ‘‘walls’’ are placed
where only solvent exists in the true binding pocket. Both
of these problems were evident when inducing a model of
the CDK2 binding site using a congeneric series of
substituted guanines [15]. As with the alignment problem,
methods that constrain the potential pocket probe config-
urations such that they more closely match what is physi-
cally responsible for observed activity patterns will aid in
generalization.
In this work, we augment the standard QMOD proce-
dure in two ways, both of which make direct use of
experimentally determined structures of the protein target
in question. The structure-guided QMOD (SG-QMOD)
approach alters steps 1 and 3 of the standard procedure and
is illustrated in Fig. 1. Aligned protein structures with their
cognate ligands (panel a) are used to help guide the model
construction process. The standard QMOD steps 1–3 cor-
respond to panels b–d of the figure, with steps 4–5 con-
solidated into panel e, and the final step corresponding to
panel f.
The SG-QMOD procedure makes use of the protein-
ligand complexes in order to derive a more accurate initial
alignment hypothesis than is possible using molecular
similarity alone (panel b). Rather than relying solely upon
molecular similarity, the training ligands to be used for the
alignment hypothesis are docked into the representative
crystal structures and high scoring poses are retained for
each. A single pose for each is selected such that the
combined mutual 3D similarity among the training ligands
(including the known bound ligand poses) is maximized.
This produces an alignment hypothesis that is informed
both by optimal fitting with the proteins and by 3D shape
and electrostatic concordance with known ligand
configurations.
Additionally, the protein structures are used to filter the
set of possible pocketmol probes produced by the standard
probe generation procedure. This process removes probes
that are not within the vicinity of similar chemical frag-
ments in the protein binding pockets. A comparison of
panels a and d in Fig. 1 reveals good overall coverage of
the binding site between the protein structures in a and the
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initial probe set in d. Regions at the front and right-side are
adequately covered by the initial rich probe set, while the
hinge-binding region at the top is correctly represented by
steric and polar probes, and the opening of the pocket at
left remains unoccupied. This limits the initial pool to those
that are spatially and chemically justifiable. Apart from
these two modifications, the standard model induction and
testing procedures are used.
SG-QMOD was applied to CDK2, with detailed com-
parisons to the standard QMOD approach, docking-based
predictions, and descriptor-based QSAR modeling. Two
inhibitor sets were used, the ‘‘congeneric set’’ consisting of
substituted guanine inhibitors and the ‘‘diverse set’’ con-
sisting of structurally variant inhibitors with known bound
configurations. Additional comparisons included structure
activity data for urokinase, Chk1, and PTP1b [18].
There were three primary results of this study. First, the
SG-QMOD procedure was predictive within the congeneric
CDK2 series, but SG-QMOD yielded performance similar to
the purely ligand-based QMOD approach in terms of
numerical accuracy. This also held for the descriptor-based
QSAR predictions, with statistically indistinguishable
results from the two QMOD variants. Second, for the
structurally diverse set of molecules, the structure-guided
approach was more widely applicable and accurate in both
activity and pose predictions. Here, the SG-QMOD proce-
dure yielded much better results than the purely ligand-based
QMOD method, direct molecular docking, or descriptor-
based QSAR. Third, for all four targets, the structure-guided
procedure produced models that shared high physical con-
cordance with the protein targets under investigation. For
example, in the CDK2 case, the induced structure-guided
model showed a very direct relationship with key kinase
binding site elements known for their role in ligand recog-
nition. In the urokinase case, the key interactions within the
P1 recognition pocket were similarly well recapitulated. The
integration of structural information provided improvements
in activity prediction, bioactive pose prediction, and fidelity
of induced pocketmols to experimentally determined struc-
tures of binding sites.
In addition to the methodological results, another theme
emerged from the comparison of different methods. Within
A B C
D E F
Fig. 1 Derivation and testing of a CDK2 pocketmol using the SG-
QMOD procedure: a a collection of multiple protein structures are
aligned (bound ligands shown with a green surface); b an alignment
seed hypothesis, guided both by docking and similarity to known
bound ligands; c alignments for each training ligand are produced; d a
large set of probes (many thousands) is created where interactions
may exist; probes are filtered based on the location of similar type
fragments in the protein pockets; e a small near-optimal set of probes
(atom colored surface) is selected, followed by iterative probe and
pose refinement; f new molecules are tested by flexible alignment into
the final pocketmol to optimize their scores
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chemical series where the effect of substituent changes is
largely additive, it is difficult to discern performance dif-
ferences between computationally expedient regression-
based methods, moderately expensive approaches such as
QMOD, or very intensive calculations such as dynamics-
based simulation approaches. However, additivity occa-
sionally breaks down quite dramatically [15, 16], and a
very common case in medicinal chemistry requires pre-
dictions on molecules quite different from those upon
which a model is constructed. In these cases, stark per-
formance differences emerge among different methods.
Methods and data
The primary results of this study involve two sets of CDK2
inhibitors, with additional control experiments on three
targets that were the subject of another study [18], all of
which are described here. Procedural details of the two new
algorithmic components that SG-QMOD adds to the stan-
dard QMOD protocol are also presented in this section.
Additional details regarding computational and data prep-
aration procedures presented in the ‘‘Experimental
section.’’
Molecular and activity data
For the CDK2 study, the availability of a large number of
compounds within a particular chemical series was com-
plemented by a set of inhibitors with diverse scaffolds
whose bound structures were known. The congeneric series
of inhibitors included 80 substituted guanine CDK2
inhibitors whose structures and activities were published
from 2002–2006 [19–21]. The 80 congeners were divided
randomly between 30 used for training and 50 used for
testing, following an earlier report [15]. Figure 2 shows
examples of the congeneric series (molecules 1–3).
A set of 77 X-ray co-crystal structures of CDK2 were
curated from Binding MOAD [22] and the RCSB Protein
Data Bank [23], with assay values also gathered from
BindingDB [24] where available. The co-crystal structures
were organized into two groups, one for use in structural
guidance during training and the other to provide a diverse
set for testing. The first group had deposition dates that
preceded publication of the aforementioned 80 inhibitors and
included 26 structures [25]. The 26 bound ligands were all
structurally different from the guanine series. From this set,
five X-ray crystal structures were chosen based on binding
pocket configurational diversity. These five were used for
structure-guided model construction. Figure 2 shows the
cognate ligands of these structures (molecules 4–9, respec-
tively corresponding to 1QMZ, 1KE6, 1KE8, 1JVP, and
1H07). The date cutoff was chosen such that the structures
used to inform model construction would have been avail-
able at the time that the congeneric series was being
investigated.
The remaining set of 52 structurally diverse compounds
were used as a challenging test of the QMOD models, both
for binding affinity prediction and for pose prediction.
Careful inspection was carried out to eliminate inadvertent
retesting of training molecules to ensure the integrity of
‘‘blind’’ tests. The automated curation procedure for the
diverse test set was designed to identify only those ligands
whose cognate PDB structure was deposited after initial
publication of the guanine series. However, subsequent
detailed manual inspection of the deposition records indi-
cated that 4 of the 52 had been deposited earlier. None-
theless, these were of varied chemical structure, and the 52
molecule test set was predominated by future compounds
relative to the initial investigation of the congeneric
guanine series.
Fig. 2 CDK2 ligands used for the alignment hypothesis. Molecules
1–3 are the top 3 most active ligands derived from the CDK2 training
series used in this study. Molecules 4–9 are the bound ligands
extracted from the five protein structures chosen for structural
guidance (all shown with activity values were included in the training
set)
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A comparison to the MM-PBSA approach was also
made, utilizing three targets (urokinase, Chk1, and PTP1b),
originally reported by Brown and Muchmore [18]. Each
data set was divided randomly between half used for
training and the remaining half used for testing. The uro-
kinase data set contained 75 ligands (37 training and 38
testing). The Chk1 set contained 123 ligands (59/57 train/
test, with seven molecules not used due to structural errors
or duplications). The PTP1b set contained 110 (55/55 train/
test). In addition, PDB co-crystal structures with bound
non-covalent inhibitors were organized for each data set to
serve as a selection pool from which structures were cho-
sen for model guidance (as with CDK2).
Structural guidance in alignment generation
The standard QMOD procedure would make use of mol-
ecules 1–3 using molecular similarity alone. Given the
common core structure and significant flexibility in some
of the compounds, many high-scoring alignment solutions
that are inconsistent with fitting into the CDK2 binding site
are generated. Given that the SG-QMOD procedure makes
direct use of experimentally determined structures to aid in
determining molecular alignment, the obvious approach
would be to simply dock the chosen molecules and make
use of their top-scoring poses. The difficulty with this
straightforward approach is that the ‘‘cross-docking’’
problem is well-established to be challenging for docking
algorithms [26, 27]. With aggressive search procedures,
using conformational variants of the protein binding sites
during docking, it is possible to frequently obtain an
accurate pose among the top scoring set, but it is often the
case that the single top scoring pose is inaccurate.
Consequently, the SG-QMOD procedure combines the
docking approach with molecular similarity, as follows:
1. The ligands to be used in an alignment hypothesis are
docked using a standard multi-structure docking pro-
tocol [26]. The top 100 highest scoring poses for each
are retained. For CDK2, molecules 1–3 in Fig. 2 were
subjected to docking. Default parameters for multi-
structure docking with Surflex-Dock are used [28].
2. The poses from step 1 are combined with those of the
cognate ligands from the multi-structure docking. For
CDK2, the cognate ligands were molecules 4–9 in
Fig. 2. Molecules 1–3 have uncertainty, existing as
multiple poses, but molecules 4–9 have a single pose
each.
3. The pairwise 3D molecular similarities for all poses of
all ligands are computed and retained. Default param-
eters for Surflex-Sim are used [9].
4. A brute-force optimization procedure is used to
identify the single pose for each molecule which
maximizes the sum of all pairwise molecular similarity
values.
Figure 3 shows the result of this procedure applied to
the CDK2 case. Panel A shows the selected poses super-
imposed with one of the known bound ligands (compound
5, PDB code 1KE6). There is high concordance among the
hinge-binding polar moieties at the top-right, a matching
ring orientation in the center, and matching disposition of
the sulfonamide/sulfone substituents at the left. Panel b
shows the same alignment, but includes the bound pose of a
guanine analog not used for model construction (compound
10, PDB code 1H1S). The chosen poses for training com-
pounds 1–3 fully mirrored compound 10.
Figure 4 shows the contrasting results obtained by using
pure molecular similarity or pure docking. In the former case
(panel a), an extended conformation of the guanine analogs
was chosen, with nitrogen-substituent being flipped opposite
to the oxygen-substituent. This configuration is clearly not
correct in terms of the absolute geometry of such inhibitors
within the CDK2 pocket (see Fig. 3). However, because the
correspondence of parts among the inhibitors is reasonable, it
is possible to induce a model that is predictive within this
series, as will be discussed below. In the case of docking, the
five highest scoring poses for each of the three ligands are
shown (panel b), each of which fall within a narrow window
of scores. There was some positional variation of the
hydrophobic substituent, but the uncertainty in the orienta-
tions on the left-hand side were more substantial, allowing
for two alternatives for the sulfonamide substituent. Within
the collection of docked poses, however, there were a set of
poses that were both concordant with one another and also
with the bound poses of molecules 4–9 used to help guide the
SG-QMOD procedure. Panel c shows these poses, which
correctly disambiguate the orientation of the sulfonamide
substituent as well as providing a tight initial alignment of
the hydrophobic pendant group.
The SG-QMOD alignment procedure makes use of
docking, but it employs molecular similarity as an addi-
tional constraint, thus allowing a more coherent set of
poses to be derived. Consideration of similarity to known
bound configurations of other ligands offers the type of
guidance that an experienced modeler may employ when
working with a target where additional experimental
information exists. In the CDK2 case, poses chosen in this
fashion are reasonable, based the concordance between the
guanine analogs to a highly similar analog whose bound
structure was known (see Fig. 3).
Structural guidance in pocketmol probe generation
Lacking any information about the true binding site, the
standard QMOD procedure simply identifies the positions
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of all three types of probes that can make favorable inter-
actions with any part of any pose of an active training
ligand. For the alignment hypothesis depicted in Fig. 3, this
results in the probe set shown in Fig. 5. In contrast to the
filtered set shown in Fig. 1d, the full set locates probes in
places that are exposed to solvent. While it is possible to
learn that a part of space is not part of the true pocket, this
requires the presence of structural variation within a ligand
training set in all such locations.
In the structure-guided procedure, the probes are filtered
so that a probe will only exist in a position that is close to
an atom of similar type within any of the protein pocket
variants being used. In order to survive the process, a steric
probe must fall within 1.0 A˚ of a hydrophobic atom of a
protein variant, and a polar probe must fall within 2.0 A˚ of
an atom of the same polarity on a protein variant.
Fig. 3 Alignment hypothesis
yields conformational
concordance among highly
active CDK2 ligands while
satisfying physical constraints
of observed bound
conformations: a the hypothesis
alignment of the top three most
active CDK2 ligands (1–3, atom
color) with crystal structure
bound pose of 5 (green);
b hypothesis alignment of
ligands 1–3 with bound pose of
structurally related analog 10
(PDB code: 1H1S, orange).





Fig. 4 Variations of alignment hypotheses: a the top-scoring result of
pure ligand-based hypothesis generation for molecules 1–3; b the five
top-scoring docked poses of the same three molecules; c the three
poses from among 100 docked poses selected based upon mutual
similarity, including the cognate ligands of structures used for
guidance
Fig. 5 The full probe set from the standard QMOD procedure, prior
to the filtering step used in the structure-guided approach
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Comparing Fig. 1a with d, the filtered probe positions
correspond to the occupancy dictated by the aligned protein
structures, representing a logical ‘‘OR’’ among the different
conformations. The process yields a set of probes that
allow for variability beyond what is seen within the crystal
structures used, but the probes are constrained to have
some geometric support from those structures.
Results and discussion
The target case of CDK2 offers a particularly rich example,
with hundreds of protein structures available, bound to a
diverse complement of inhibitors. The available structures
covered significant conformational variation in the enzyme
binding site. For CDK2, it was possible to assess perfor-
mance of the SG-QMOD procedure on both affinity pre-
diction and pose prediction and to compare performance
with the standard QMOD procedure, direct molecular
docking, and to descriptor-based QSAR predictions. The
comparative performance of the methods varied consider-
ably on the test against inhibitors of diverse chemical
structures, and these results will be presented first.
Comparison of SG-QMOD to MM-PBSA was also
made, making use of a comprehensive study of three tar-
gets for which data were made available [18]. In these
cases, SG-QMOD performed similarly to the CDK2 case.
However, structural variety among the ligand sets was
more limited, reducing the power to discern comparative
differences.
CDK2: congeneric and diverse test ligands
A common situation in lead optimization efforts arises
where the precise bound configuration of a series under
active consideration may not be known, though there may
be significant structural information on other chemical
series. This situation is studied here using the congeneric
set of CDK2 inhibitors coupled with structural guidance.
The SG-QMOD procedure identified good initial poses for
training molecules 1–3, as discussed above, from which the
alignments for the remaining molecules were generated as
in the standard procedure. The SG-QMOD probe genera-
tion method made use of protein structure information to
influence the pool of probes for pocket construction
(Fig. 1d). From this point, the standard model induction
procedure was carried out.
Predictive performance: within-series and beyond-series
Figure 6 shows the final pocketmol, and Fig. 7 shows
prediction performance on the 50 CDK2 substituted
guanine inhibitors. The model was highly predictive within
this series, producing an average error of 0.61 log units and
a Kendall’s Tau rank correlation of 0.73 (p \ 0.01). The
final pocketmol with the predicted pose of molecule 12 is
shown. The QMOD procedure estimated confidence for a
new ligand based on the similarity of predicted bound pose
to that of a training molecule. Here, high confidence
stemmed from training molecule 11, and the predicted
activity of compound 12 (pKi = 7.7) was very close to
correct (a 0.5 log unit deviation). Performance on the entire
set is shown at right, highlighting the excellent correlation.
For the purposes of synthetic candidate prioritization, it
was notable that 7 out of the top 10 predicted test mole-
cules appeared among the top 10 bona fide most potent
molecules in the entire test set.
Another common situation requires transfer of SAR
from one series to other series, in the case where a change
of scaffold my be required. Figure 8 shows representative
examples of predictions made on the diverse test set with
Fig. 6 The final SG-QMOD CDK2 pocketmol is shown in thin sticks
and skin, with molecule 12 (atom-colored sticks) in its final predicted
pose. The high confidence reported for 12 derived from similarity to
training molecule 11 (cyan). The predicted activity of 12 was just a
0.5 log unit deviation of its actual pKi
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the structure-guided model. Panel a contains a substituted
guanine whose bound pose was determined experimentally.
The predicted and experimental poses deviated only with
respect to the end of the flexible tail at the left-hand side,
which reaches toward a solvent-exposed area. High confi-
dence and low error were to be expected from a close
analog to those on which the model was trained. The
molecule in Panel b shares direct structural similarity with
respect to the left-hand-side of the training series, but the
central scaffold and lower substituent are quite different.
Again, though, all aspects of the prediction were accurate.
Panel c shows a test ligand that deviated further still,
sharing very little in common with any training molecules,
which was reflected in the low confidence value, but pre-
diction errors were still small. Panel d shows a structural
elaboration of that shown in c, where the predicted
improvement in pKi was 1.6, but the actual was 1.3,
resulting in an over-prediction of activity by 0.9 log units.
However, the indication of substantial improvement was
correct, as was the predicted bound configuration of the
inhibitor.
Predictive performance for activity and pose is sum-
marized for the diverse inhibitor set in Table 1 (top).
Overall, SG-QMOD yielded an average activity prediction
error of 1.1 (units of pKi) and an average RMSD 1.8 A˚,
with a Kendall’s Tau rank correlation of 0.27 (p = 0.01). As
expected, the model performed systematically better on
ligands for which confidence was higher. At confidence
levels of 0.7 and above, average RMSD was 1.2 A˚, and the
ranking was nearly perfect (Tau = 0.85, p \ 0.01).
Given that experimentally determined protein structures
are being used in the SG-QMOD procedure, it is natural to
wonder how direct use of the structures for affinity and
pose prediction performs. It is particularly apt here,
because QMOD makes use of the same scoring function as
Surflex-Dock in quantifying the intermolecular interactions
between ligand and either pocketmol (for QMOD) or
protein binding site (for Surflex-Dock). Beginning with
similar conditions used for the SG-QMOD approach (i.e.
the same five protein crystal structures with bound ligands),
we docked the set of 52 diverse inhibitors to assess the
performance of naı¨ve and direct use of structural infor-
mation. Table 1 (bottom) summarizes the results, broken
down by groups of molecules as defined by the SG-QMOD
confidence levels. In all cases, SG-QMOD produced much
lower absolute errors.
Two aspects were somewhat surprising. First, the
docking approach produced better than expected results,
with statistically non-random rankings of affinity in the two
larger molecule subsets despite high absolute errors. SG-
QMOD performance was still more robust, with the quality
of the rankings increasing among the more confidently
predicted molecules, even producing statistically signifi-
cant ranking results within the smallest group. Second, and
perhaps more surprisingly, the pose prediction perfor-
mance of SG-QMOD was better than the pure docking
approach as well. We speculate that the process of identi-
fying parsimonious structural explanations for ligand
affinity helped identify key features for ligand binding,
which in turn led to improvements in pose identification
and ranking.
Relationship of the induced pocket model to the CDK2
binding site
In the foregoing, we have discussed the effects of inte-
grating protein structural information on accurate predic-
tion of ligand activity and bioactive pose within the protein
pocket. Another important attribute is the physical rela-
tionship of the induced model with the protein binding
pocket. The pocketmol is not a literal re-representation of a
binding pocket, being instead generally more sparse,
reflecting the physical characteristics that best explain the
activities of known ligands. Pocket flexibility can be rep-
resented in the pocketmol structure with multiple alterna-
tive probes, and complex electrostatic fields can be

















Fig. 7 SG-QMOD produced accurate predictions within the CDK2
substituted guanine series. Activity prediction performance on the
entire guanine series test set is plotted. The overall prediction error
was 0.61, with a Kendall’s Tau rank correlation of 0.73 (p\0.01, by
permutation analysis), and an r2 of 0.71. Note that while, in this case,
overprediction was more common than underprediction, this is not a
general trend
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To the extent that a pocketmol accurately reflects true
binding pocket geometries, there will be broader compat-
ibility with diverse ligands exhibiting significant structural
novelty. Figure 9 highlights the physical relationship
between the model (probes shown in thick sticks) and the
crystallographically determined binding site of 2G9X (thin
sticks) with a bound ligand (green). Key interaction points
on the hinge binding region are well represented by the
induced pocketmol. Electrostatic interactions provided by
Asp86 are modeled by an acceptor probe, and two hydro-
phobic probes flanking the right and left sides of compound
13 closely match physical constraints provided by Asp86
and ILe10 (Fig. 9a). The backbone carbonyl of Glu81 is
modeled by an acceptor probe and the NH of Leu83 is
represented by donor probes (Fig. 9b). Panel c shows an
outward view of the buried portion of the pocket high-
lighting structural concordance between a series of
hydrophobic probes and the arc-like shape of the pocket
defined by ILe10, Ala31, Val64 and hinge binding residues
80–83. The electrostatic interaction between Lys89 and the
sulfone group is modeled by a donor probe (Fig. 9d).
In addition, the pocketmol provided a highly concordant
physical shape of the binding pocket, accurately charac-
terizing the overall structural configuration. Figure 10
illustrates these shared characteristics. The front view











Fig. 8 The structure-guided modeling procedure produced accurate
pose and activity predictions on the diverse set of 52 CDK2 inhibitors.
Panels a shows an example of a substituted guanine compound
closely related to the training molecules, and b–d show representative
examples of diverse CDK2 ligands in their predicted poses (atom-
colored) superimposed with their crystal structure bound pose (green)
Table 1 SG-QMOD and docking results for 52 structurally diverse CDK2 inhibitors
Confidence NMols pKi range Average error (pKi) Kendall’s Tau p value RMSD (A˚)
SG-QMOD
0.7 9 5.0–8.5 0.7 0.85 \0.01 1.2
0.5 39 4.5–9.9 1.0 0.30 \0.01 1.6
All 52 3.5–9.9 1.1 0.27 0.01 1.8
Direct docking
0.7 9 5.0–8.5 2.2 0.43 0.11 2.5
0.5 39 4.5–9.9 2.0 0.26 0.02 2.4
All 52 3.5–9.9 1.8 0.24 0.01 2.4
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the binding pocket (blue), with coverage of the perimeter
of the binding cavity. The side-view shows a rotated and
clipped view of the pocketmol and protein, highlighting
similarity in overall volume between the pocketmol and
binding pocket. Note that the flexible ‘‘tail’’ of 13, where a
deviation exists between the predicted and bound poses,
protrudes into solvent. The charged secondary amine,
however, interacts with the pocketmol probe that correctly
represents the contribution of Asp86 (see Fig. 10a). In
cases such as in CDK2, where a lysine sidechain is in a
solvent-exposed position, the degree of importance for
binding affinity can be difficult to assess. The SG-QMOD
approach allows the ligand activity data to help make that
determination in a fashion that is compatible with the
known structural information.
To further quantify the degree of concordance between
the pocketmol and the CDK2 binding pocket, we examined
the relationship between CDK2 pocket atoms that were
particularly important for ligand binding and the closeness
of matching SG-QMOD pocketmol probes. Recall that the
probe generation procedure produces several thousand
probes, which in the SG-QMOD procedure are filtered to
retain those that are close to matching protein atoms. The
filtered probe set, from which the learning process begins,
contained a matching probe for essentially every protein
atom that was proximal to the binding pocket. So, the
extent to which the final composition and fine positioning
of the pocketmol probes corresponded to important protein
pocket atoms was driven by finding a configuration that fit
the activity data. All intermolecular atomic contacts of the
diverse 52 ligand set (in their crystallographic poses) and
the aligned set of five CDK2 protein structures were
identified. The CDK2 binding pocket atoms were parti-
tioned into two groups: (1) pocket atoms with close contact
(surface distance of \ 0.5 A˚) to 90 % or more of the
ligands; and (2) those with at least one close contact but not
more than with 10 % of the ligands.
For each of the two groups, for each protein pocket
atom, the distance to the nearest pocketmol atom of
matching type was computed. This resulted in two
Fig. 9 The induced pocketmol from the structure-guided procedure
matches key physical characteristics of the binding pocket. The
predicted pose of compound 13 (gray) is shown with the bound pose
(green) to provide a frame of reference. Panels a–d provide detailed
snapshots of key regions of the binding pocket that are well
represented by the pocket model. a Polar aspects of Asp86 are
captured by an acceptor probe and two hydrophobic probes provide
matching physical constraints on the right and left-side of the pocket.
b The backbone carbonyl of Glu81 is modeled by an acceptor probe
and the NH group of Leu83 is captured by two donor probes.
c Hydrophobic probes (shown with a transparent surface) model the
physical shape of the buried pocket region defined by ILe10, Ala31,
Val64, and hinge residues 80–83. d Lys89 is represented by a donor
probe at the opening of the pocket
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distributions of distances: one corresponding to those
pocket atoms that participated in close contacts with the 52
test ligands very frequently (e.g. the hinge-binding atoms)
and the other corresponding to the pocket atoms in infre-
quent contact with the ligands. The two distributions of
pocketmol probe distances were statistically very different
(p  1 9 10-6 by Kolmogorov–Smirnov). In particular,
the protein atoms with high-participation had a matching
pocketmol probe within 2.0 A˚ 70 % of the time. The low-
participation atoms had a matching pocketmol probe less
than 30 % of the time.
The pocketmol induction process made use of 30 guanine
analogs and the six non-guanine compounds from Fig. 2
along with corresponding activity data. The 52 compounds
used to partition the protein atoms for this analysis were
from the blind test set of diverse compounds. The rela-
tionship between a protein atom having frequent interaction
with these molecules and being more likely to have a
matching pocketmol probe arose from the model induction
process. It seems likely that part of the reason for improved
performance in pose prediction for SG-QMOD compared
with direct docking stemmed from the enrichment within
the pocketmol for atoms that are important for binding.
Comparison to standard QMOD
The particular substituted guanine chemical series was the
subject of a previous QMOD study, where no structural
guidance was used [15]. Here, a direct comparison to the
structure-guided model was made by constructing a stan-
dard QMOD model for CDK2 using only the substituted
guanine series (i.e. not including compounds 4–9 in train-
ing). Figure 4a depicts the corresponding alignment
hypothesis. The standard model yielded numerical predic-
tive performance that was statistically equivalent to what
was observed for the structure-guided procedure on the 50
compound guanine-based inhibitor test set (mean predic-
tion error of 0.5 with a Kendall’s Tau rank score of 0.73).
This is not especially surprising, as many QSAR approa-
ches can perform well within a chemical series, especially
if the separation of training and testing is done through
random selection.
However, when we considered performance on the 52
chemically diverse CDK2 inhibitors with known bound
configurations, we observed much improved performance
using the structure-guided approach than using the control
procedure (results summarized for SG-QMOD in Table 1).
The standard ligand-based QMOD model yielded rank
correlation performance indistinguishable from random on
the full set of 52 inhibitors, with average RMSD [ 3.7A˚,
but the SG-QMOD model yielded significant rank corre-
lation and mean RMSD of 1.2 A˚. For the control QMOD
model, only when the confidence threshold was raised
sufficiently to exclude all but 6 test compounds did rank
correlation become significant (Tau = 0.82, mean error =
1.2), but the mean RMSD was unchanged. Overall, the
Fig. 10 The structure-guided QMOD procedure produces a pocket-
mol that captures the overall shape and electrostatic elements of the
CDK2 binding pocket. The 2G9X binding pocket is shown with a
blue surface and with the final pocketmol as a surface. The predicted
pose of compound 13 (atom-colored sticks) is shown with its bound
pose (green sticks)
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structure-guided model predicted 46 % of inhibitors with
errors \ 0.75 log units, 61 % with errors \ 1.0, and 78 %
\ 1.5. The standard ligand-based procedure, yielded,
respectively: 10, 16, and 30 %.
Comparison to descriptor-based QSAR
Given that the QSAR problem itself can be addressed by a
range of methods, it is interesting to ask how well simpler
approaches perform. As in our previous study involving
gyrase [17], here we applied descriptor-based QSAR using
the random forest learning (RF) algorithm (see ‘‘Experi-
mental section’’ for details).
RF as a general QSAR control
In the previous study, which focused on iterative temporal
model refinement, there were two interesting observations
regarding the RF versus QMOD approaches. First, the RF
approach performed quite well in a purely numerical sense
with respect to prediction accuracy, identifying comparable
numbers of active compounds to the QMOD approach. Our
expectation had been that because the QMOD model
exhibited strong concordance to the structure of the bio-
logical target, i.e. that it was making predictions for the
right reasons, that it would yield notably better perfor-
mance in identifying active ligands over the iterative
experiment. The second surprise had to do with the char-
acteristics of the potent compounds uncovered by the two
methods. The primary difference between the QMOD
‘‘winners’’ and those of the RF approach was not in number
but in kind. Those for the QMOD approach had much
greater structural diversity, representing quite different
ways to effectively inhibit the gyrase target. The RF
approach, by contrast, identified a collection of highly self-
similar winners.
In the report that introduced QMOD [7], a similar test
procedure was employed as we have here, restricting
training to a single chemical series of amino-tetralin 5HT1a
ligands, but tests were carried out on diverse ligands, many
of which had been discovered much later. At the time of
that study, we did not employ the RF descriptor-based
approach as a standard control. However, to better under-
stand the value of this type of control, we applied RF on the
5HT1a set, training on 20 ligands and testing on two sets.
The first set contained 35 compounds structurally related to
the training set, and the RF approach produced statistically
indistinguishable rank performance to the QMOD results
(Kendall’s Tau of 0.39 for the former and 0.38 for the
latter, both having p values \ 0.01). The second set con-
tained 32 diverse compounds, of which the activities of 17
were supported by multiple independent assays. For the
diverse set, the RF approach yielded performance no better
than random on the full set (n = 32, Tau = 0.17, p = 0.17) or
on the subset (n = 17, Tau = 0.28, p = 0.09). QMOD
yielded statistically significant rank performance on both
sets, respectively producing Tau of 0.29 and 0.51 (p = 0.03
and p \ 0.01). The RF approach can be surprisingly
accurate and robust, and the cases in which it yields poor
performance represent interesting challenges for predictive
activity modeling.
RF applied to CDK2
The RF approach was applied here, training on the 30
guanine analogs and testing on the diverse 52 inhibitor set.
The results here largely paralleled what we found in the
previous gyrase study. However, given the increased
structural diversity of the test set, the overall predictive
performance for the RF method was lower than for QMOD
(results summarized in Table 2). Overall, for the 52
inhibitors, the RF approach yielded Kendall’s Tau of 0.21
(p = 0.05), with average error of 1.2 pKi units (comparable
values for QMOD were Tau of 0.27 (p \ 0.01) and mean
error of 1.1). The differences were more substantial as the
relative confidence of each method was considered. For
QMOD, its standard confidence measure was applied
(described earlier). For the RF approach, the analogous
computation was made, equating confidence for each test
ligand to the most similar training ligand by Tanimoto
similarity of the descriptor fingerprint used. For the least
confident half of the test set, the RF method produced
random rankings: Tau = 0.12 (p = 0.26) and mean error =
1.4. But for the QMOD method, overall set performance
was nearly matched by performance on the bottom half:
Tau = 0.34 (p = 0.03) and mean error = 1.0. Conversely, for
the top quintile of confidence, the RF method produced
marginal performance: Tau = 0.38 (p = 0.13) and mean
error = 1.1. But QMOD performed well, yielding Tau =
0.87 (p \ 0.01) and mean error of 0.65.
Table 2 Comparison of QMOD to RF on 52 diverse CDK2 ligands







Top confidence quintile 10 0.87 \0.01 0.65 1.3
Top half 26 0.30 0.03 1.1 1.5
Bottom half 26 0.34 0.03 1.0 2.2
All 52 0.27 \0.01 1.1 1.8
Random forest
Top confidence quintile 10 0.38 0.13 1.1 NA
Top half 26 0.35 0.02 1.1 NA
Bottom half 26 0.12 0.27 1.4 NA
All 52 0.21 0.05 1.2 NA
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Structural diversity of identified winners
Of the top five compounds predicted to be most active,
QMOD correctly identified five with pKi C 7.1, and the RF
approach identified just three such compounds. More
importantly, as seen in Fig. 11, the relatively potent com-
pounds identified by the QMOD approach were of much
more varied chemical structure than seen for the RF
approach. None of the five SG-QMOD ‘‘winners’’ were of
the substituted guanine class that dominated the training
set. For the RF winners, two of the three were variations on
this scaffold. Generally, for the RF approach to make a
prediction at the extremum of activity, the structure in
question must share significant topology with training
compounds. The QMOD approach, by contrast, is agnostic
to topology, and is sensitive only to the degree that the new
molecule fits into and complements the pocketmol. Here,
we see that the RF predictions dramatically underpredict
activity for the SG-QMOD winners (by about 2.0 log
units). In contrast, the SG-QMOD predictions were more
accurate than those made by RF on all of the RF winners.
It is also worth noting that, while numerical prediction
of affinity has utility, accurate prediction of binding modes
for novel ligands during lead optimization also has sub-
stantial value in guiding the design process. For the three
RF winners, SG-QMOD produced an average RMSD of
1.5 A˚. For its own five winners, the SG-QMOD approach
produced a mean RMSD of 1.7 A˚, establishing to some
degree that the predictions were being made for the ‘‘right’’
reasons. The relative value of pose prediction compared
with affinity prediction is both subjective and project-
dependent. However, as compounds must be contemplated
with divergent scaffolds from those with available activity
data, methods such as the SG-QMOD approach, which
reach toward causal inference rather than simple correla-
tive inference, can produce better results across multiple
criteria.
Comparison to simulation-based affinity prediction
The foregoing comparisons to direct molecule docking and
to descriptor-based QSAR addressed the question of how
well widely-used and easily applied structure-based and
ligand-based methods would fare in comparison to the SG-
QMOD approach. In the case of straightforward docking,
the results were not altogether surprising, given the known
limitations of docking approaches for binding affinity
estimation. In the case of descriptor-based QSAR, the
results paralleled our previous observations [17]. Direct
comparison to more complex simulation-based approaches
were not explored on the CDK2 data set. These represent
an entirely different level of computational complexity,
and such approaches also require deep methodological
expertise. Highly experienced practitioners of such meth-
ods report that, while accurate for some systems, they can
produce poor results for others without obvious explana-
tions. Apart from methodological and computational
complexity, each of which can be overcome, the inability
to know, a priori, which systems will be amenable to
simulation-based approaches remains a serious practical
challenge. Chodera et al. [29], Gilson and Zhou [30], and
Blaney [31] provide excellent reviews of the state-of-the-
art, theoretical basis, and limitations for such methods.
One nicely done study applying MM-PBSA by Brown
and Muchmore [18] demonstrated results of sufficient
quality to be potentially useful for guiding lead
Fig. 11 The structure-guided QMOD procedure top five predictions
included five molecules with pKi C 7.1 (top row). The RF proce-
dure’s top five predictions included three such potent compounds
(bottom row). The PDB codes and experimental pKi are shown in the
labels, along with the magnitude and sign of the prediction error by
the two procedures
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optimization. Figure 12 shows representative examples of
the ligands for urokinase, Chk1, and PTP1b. There are a
number of considerations that make direct comparison of
the SG-QMOD and MM-PBSA results complicated. First,
the latter method does not require any training, being
instead a simulation-based approach that had been auto-
matically applied. For this comparison, the molecular data
was partitioned randomly into 50/50 sets for training and
testing of SG-QMOD. We avoided leave-one-out cross-
validation in order to make a more realistic test. None-
theless, training on a proportion of data offered an
advantage to the QMOD method. Second, results from the
MM-PBSA approach represent best-case performance in
two respects. The experimentally determined bound con-
figuration for each ligand was used in the simulations, thus
obviating any dependence on uncertainty in ligand pose. To
varying extents, but particularly in the case of PTP1b, with
very large and flexible ligands, this represents a significant
advantage for the simulation approach. Also, in reporting
standard errors, the authors linearly re-scaled the actual
prediction values in order to minimize RMSE, owing to the
sharp difference in slope and intercept for predicted versus
experimental pKi values.
The SG-QMOD procedure described for the CDK2
example above was applied to the three targets (see
‘‘Experimental section’’ for details). Figure 13 shows the
resulting urokinase pocketmol aligned with the urokinase
protein structure, depicting the predicted pose of the
inhibitor from Fig. 12. The pocketmol accurately repre-
sents the shape and polar characteristics of the binding
pocket while making an accurate prediction of binding
activity and pose of a test molecule. The primary aspect of
pose uncertainty for this relatively rigid compound was the
orientation of the amide substituent. The prediction arising
from fitting to the pocketmol was close to correct, driven
by a favorable interaction with an acceptor probe (top left
of panel b) that corresponds well with one from the protein
(see panel a). The RMSD for this compound was 1.3 A˚.
The learned representation of the deep P1 pocket structure
(panel c) shows direct correspondence between the
acceptor probes of the SG-QMOD model and analogous
functionality within the protein. The probe placement and
orientation is driven by the requirement to produce an
energetic field, which, given the functional form and
parameterization of the intermolecular scoring function,
produces the correct activity values at the extremum of
molecular score with respect to pose. This physical
abstraction allows better reproduction and prediction of
activities across a wide range of new molecules than can be
achieved through direct use of docking.
Automated application of the MM-PBSA method and
the SG-QMOD method gave rise to the results summarized
in Table 3 (numbers in parentheses are 95 % confidence
intervals for the statistics). With the caveat that the QMOD
approach makes use of training data and that the applica-
tion of MM-PBSA benefited from having no uncertainty in
the poses of any molecules, the comparison based on the
correlation metric shows very similar performance. For
urokinase, QMOD performed slightly better, and for
PTP1b the MM-PBSA approach performed slightly better.
However, the differences were marginal. Comparison of
the RMSE values is less informative, because the values for
MM-PBSA were linearly re-scaled to minimize the resid-
ual squared errors. Without such a correction, the QMOD
error magnitudes were much lower. Overall, given that the
MM-PBSA results represent a best-case scenario for a
simulation-based technique, it is encouraging that the
realistic application of SG-QMOD produced comparable
results that could be beneficial in a real-world lead-opti-
mization application.
Conclusions
The core Surflex-QMOD methodology has been validated
in prior studies [7, 15–17]. The significance here relates to
Fig. 12 Examples of potent compounds from the three targets of the
Brown/Muchmore [18] MM-PBSA study
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the integration of information from protein structures
within the QMOD model induction process. Within the
congeneric chemical series studied here, the SG-QMOD
procedure performed similarly to the purely ligand-based
QMOD approach with respect to prediction error magni-
tude and activity ranking. As we have observed before,
such models were unable to correctly identify absolute
bound configurations given data from a single chemical
series. By contrast, the structure-guided procedure offered
substantial advantages, producing models that reliably
mimicked the true protein binding sites. For structurally
diverse test molecules, such models provided much more
accurate ligand activity ranking and pose prediction. The
structure-guided models identified key characteristics
important for ligand binding and yielded excellent pose
predictions, better even than those produced by docking
Fig. 13 SG-QMOD model for
urokinase: a predicted pose
(atom-colored sticks) compared
with the crystal bound pose
(green sticks) of ligand 497 in
the context of the protein
binding pocket (PDB ID:
1OWD, blue skin with thin
sticks); b the same ligand poses
within the QMOD pocket model
(yellow skin with sticks);
c detail of the pocket model
acceptor probes interacting with
the amidine portion of the
molecule; d 2D schematic of
test molecule 497
Table 3 Comparison of SG-QMOD to MM-PBSA on three targets
Method and target N Tau p value RMSE R
SG-QMOD
Urokinase 38 0.79 \0.001 0.66 (0.51–0.81) 0.86 (0.79–0.92)
Chk1 57 0.50 \0.001 1.09 (0.88–1.27) 0.70 (0.55–0.81)
PTP1b 55 0.48 \0.001 0.99 (0.79–1.22) 0.66 (0.44–0.80)
MM-PBSA
Urokinase 75 – - 0.69 0.78
Chk1 123 – – 0.89 0.72
PTP1b 110 – – 0.66 0.83
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methods. It is important to note that the advantages
observed were often only detectable when the model test-
ing procedure followed real-world application scenarios.
Construction of the diverse CDK2 testing set was done
temporally, with the molecules on which predictions were
to be made having been reported in the future compared
with training molecules. The advantages for SG-QMOD
were most strongly observed in this test scenario, without a
guarantee that a highly similar near neighbor would exist
within the training set used for model induction. We
believe that assessment of QSAR methods using techniques
such as leave-one-out cross-validation on data sets of sin-
gle congeneric series is of limited value. In our previous
report, exploring iterative QMOD model refinement over
time, we observed strong effects on the trajectories of
discovered molecules [17]. Application of random forest
learning with molecular descriptors was accurate in a
numerical sense, but yielded pools of active compounds
with shallow structural diversity compared with those
produced by application of QMOD. Here, we observed a
similar effect, but also saw an advantage in terms of pure
predictive performance of SG-QMOD over RF on the
diverse CDK2 test set.
The QMOD method is clearly quite dependent on the
degree to which the initial ligand alignments match the true
relative configurations of the training ligands, especially
regarding generalization to compounds with divergent
scaffolds. Inclusion of diverse ligands in training or aug-
mentation with bound ligand information, as done here,
improves performance. The method is also highly dependent
on the degree of variation within the available training data.
The models cannot know what they have not seen, though
this is an issue in common across all QSAR methods. Given
protein structure information, it is possible to constrain the
search space of possible models to ones that do not deviate
very far from physical expectations. However, the search
space is still very large, and multiple pocketmol solutions
still exist. Arbitration among them is done empirically. The
most reliable method has been to select the model with the
property that the optimal training poses of molecule pairs
close in activity exhibit high 3D molecular similarity (this is
a quantitative measurement of model parsimony).
Still another area for exploration is the degree to which,
given molecules with low to mid-range potency for training,
that the method is able to help ‘‘climb the hill’’ toward more
potent molecules. Given the strong dependence on molecular
alignment, this may prove to be challenging, though active
selection of structurally novel compounds (irrespective of
their predicted potency) offers a strategy that was beneficial
in the case of bacterial gyrase [17]. With large and diverse
data sets that span long time periods becoming increasingly
available, we believe that it will be possible to systematically
investigate this question.
Apart from conclusions about the methods reported
here, there are four features that we would hope to see
become a standard part of future assessments of QSAR
methodology. First, questions should be asked about pre-
dictive performance over time, including characterization
of the structural diversity of identified active compounds.
Second, test molecules should be included that have sig-
nificant structural distance from training molecules (this is
often a natural consequence of temporal segregation).
Third, because the problem of relative alignment between
chemically different series is challenging in real-world
lead-optimization, assessment of pose prediction should
become a part of 3D-QSAR investigations. Last, robust and
easy-to-apply methods such as random forest learning
using fingerprint-based molecular descriptors should be
employed as a standard control. We believe that this
combination will help reveal the degree to which any
method will be shown to be useful in the wild, where
chemical structural novelty is often an absolute require-
ment in molecular design.
With respect to the methods reported here, experimen-
tally determined protein structural information can clearly
be profitably exploited to augment ligand structures and
associated activities. In this work, we have shown how to
construct QMOD pocketmols in a manner that is con-
strained to make use of direct structural information. The
clear extension to the method is to dispense with the
pocketmol formalism and instead to refine the structures of
an ensemble of aligned protein binding pockets. The goal
would be to use the refined ensemble directly, with a
simple docking-based scoring scheme, for affinity predic-
tion. This requires a simple extension to the multiple-
instance learning formalism, where in addition to the
ligands having the potential for variation, the binding site
itself would also be represented as variants. The score for a
ligand given an ensemble of protein pocket variants would
simply be the one resulting from the optimal fit to any of
the variants. Such an approach fits in the gap between the
approach described here and the purely physics-based
simulation-oriented methods.
In any event, the results reported here encourage the
development and use of hybrid methods that maximize
information gleaned from different sources, including both
biophysical information on protein structure and informa-
tion from experimental determination of ligand activities.
Experimental section
Ligand preparation
Ligand molecular data sets were described within the
‘‘Methods and data’’ section. All assay values were
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converted into molar pKi units (9.0 being equivalent to a Ki
of 1 nM). The standard Surflex procedure was used to
protonate, ring-search, and minimize the ligands. This
resulted in up to five conformations per inhibitor, with
protonation as expected at physiological pH. These pre-
pared structures were used for all subsequent procedures.
Computational procedures
The QMOD procedure is automatic, requiring no human
choice points. For this work, default parameters were used,
employing Surflex-QMOD version 1.5. There were two
significant algorithmic variations investigated here, com-
pared with that reported in the most recent study [17]. First,
an initialization protocol was added that incorporates multi-
structure docking and data integration that uses bound ligand
poses to guide the generation of an alignment hypothesis.
Second, a procedure was added that filters an initial probe
pool using guidance from multiple aligned protein structures
(see Fig. 1, panels a, d). All protein structures used in this
study were pre-processed using standard procedures for
structure preparation and mutual alignment [32, 33].
In the CDK2 study, five representative structures were
chosen by k-means clustering from a pool of 26 protein
structures. The top 3 most active CDK2 training ligands
(see Fig. 2 molecules 1–3) were docked against these five
structures using the standard Surflex-Dock multi-structure
docking protocol [26, 34–36]. Multi-structure docking was
carried out using Surflex-Dock v2.7, with an option to
retain up to 100 docked poses per ligand. The particular
pose used in QMOD model construction for each of these
three docked ligands was chosen to maximize the pairwise
similarity among the docked poses and the 6 co-crystal
ligands (see Fig. 2 ligands 4–9). Molecular similarity cal-
culations were carried out using Surflex-Sim v2.7.
For the MM-PBSA comparison an analogous approach
was carried out. For each data set 5 representative co-crystal
structures were chosen from their respective selection pools
using k-means clustering. These representative co-crystal
structures were used for model guidance. For the PTP1b
study the top 2 most active training ligands were docked, and
poses were generated and selected as described above. In the
urokinase and Chk1 cases the training ligands were well
represented by the selected co-crystallized ligands used for
model guidance, and so the co-crystal bound poses were
chosen for subsequent model setup.
The compounds with poses chosen as described above
were used as the alignment target in the standard QMOD
procedure to produce initial alignments for all training
molecules in all cases. The probe pool was initiated using
the standard tessellation procedure which has been
described in our earlier work [7]. This large set of
molecular probes surrounds the initial alignments of the
training ligands, where each probe makes a near-optimal
interaction with at least one active ligands pose. Initial
probe pools were then filtered using the representative
protein structures chosen for model guidance. Every probe
was evaluated against similar atom types (e.g. donors,
acceptors, hydrophobic) on the protein structures. Probes
that were within a predefined minimal distance (i.e. 2.0 A˚
polar, 1.0 A˚ hydrophobic) to similar type atoms comprised
the filtered probe pool used for model induction.
The procedure for producing a de novo pocketmol requires
a single command from a simple setup file that produces a
script. The script runs a sequence of QMOD commands that
generate initial alignment hypotheses, full alignments of
training ligands, and final pocketmols. The setup file contains
information on path names to training ligands and their
activities, which ligands to use for hypothesis generation, and
modifications to default parameters for model building if
desired. For the generation of pure ligand-based models with
no structural guidance, the standard procedure was employed.
For the structure-guided models, the augmentations just
described replaced the normal alignment hypothesis genera-
tion step and filtered the initial probe pool. All other steps
remained as in the standard protocol. By default, three models
are generated, each using different probe densities. In all
cases, the model with the highest reported parsimony was
selected for blind testing and structure evaluation.
Surflex-Dock v2.7 was also employed as a control pro-
cedure for comparing rank ordering and pose prediction
accuracy of the 52 diverse CDK2 ligands. For these com-
putations, multi-structure docking was carried out as
described above, using the same five protein crystal
structures used for the SG-QMOD approach.
Random forest learning was applied as previously
described. The random forest technique is an ensemble
classification approach that constructs multiple decision
trees using a random sampling approach to minimize
generalization errors [3, 37, 38]. We used the random forest
method implemented in version 4.6-2 of the randomForest
package for the R software environment (version 2.12.2).
Unity 988-bit fingerprints were generated using SYBYL-X
2.1 (both programs from: Certara, L.P., 9666 Olive Blvd.
Suite 425, St. Louis, MO 63132 USA). The model training
and molecule testing procedure paralleled that used for
QMOD, making use of default parameters for the RF
learning procedure. To mimic the confidence procedure,
we calculated Tanimoto similarity scores between testing
and training molecules using the Unity fingerprints. This
provided an analogous metric for measuring confidence
using features employed by the classifier.
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